Cathepsin L‐Activatable Fluorescent Probe for Real‐Time Monitoring of Drug‐Resistant Breast Cancer Cells
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202501624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Qiqi Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Organosilicon Chemistry and Materials Technology of the Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Te…. Hauptthemen laut MEDLINE: Fluorescent Dyes, Breast Neoplasms, Cathepsin L. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Interdisciplinary Research Project of Hangzhou Normal University.
Abstract (Originalsprache)
Precise identification of drug‐resistant tumor cells remains a critical challenge for optimizing therapeutic strategies and improving clinical outcomes. Herein, we present FR‐DCO, a cathepsin L (CTSL)‐activatable fluorescent probe, engineered for targeted imaging of doxorubicin‐resistant breast cancer cells (MCF‐7/ADR). Capitalizing on the overexpression of CTSL in chemoresistant malignancies, FR‐DCO integrates a CTSL‐specific dipeptide substrate (Phe‐Arg, FR) with a dicyanoisophorone (DCO) fluorophore, enabling fluorescence activation via a single‐step enzymatic cleavage. Upon hydrolysis, FR‐DCO transitions from an intramolecular charge transfer‐quenched state to an activated DCO fluorophore, achieving a 12.8‐fold enhancement in quantum yield. In vitro studies demonstrated both caveolin‐ and clathrin‐mediated endocytosis in MCF‐7/ADR cells, yielding 2.3‐fold higher fluorescence intensity than its nonresistant counterparts (MCF‐7 and 4T1). In vivo imaging in murine models revealed rapid and specific activation within drug‐resistant tumors, with intratumoral fluorescence intensity doubling that of nonresistant lesions within 20 minutes post‐injection. Notably, dual‐tumor xenograft models confirmed precise discrimination of MCF‐7/ADR tumors from 4T1 tumors, highlighting the spatial resolution of the probe. This work not only provides a molecular tool for spatiotemporal resistance monitoring, but also establishes a modular design paradigm for enzyme‐responsive probes targeting tumor microenvironment biomarkers, advancing precision oncology strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Organosilicon Chemistry and Materials Technology of the Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Technology, College of Materials, Chemistry and Chemical Engineering, Ha…
- Laboratory Animal Center, Hangzhou Normal University, Hangzhou, 311121, P. R. China.
ORCID-Profile: Shouchun Yin
Förderung
- Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Interdisciplinary Research Project of Hangzhou Normal University
- National Natural Science Foundation of China
Zitieren
APA
Yu, Q., Chen, S., Yu, L., Xu, D., & Yin, S. (2025). Cathepsin L‐Activatable Fluorescent Probe for Real‐Time Monitoring of Drug‐Resistant Breast Cancer Cells. Chemistry – A European Journal. https://doi.org/10.1002/chem.202501624
Vancouver
Yu Q, Chen S, Yu L, Xu D, Yin S. Cathepsin L‐Activatable Fluorescent Probe for Real‐Time Monitoring of Drug‐Resistant Breast Cancer Cells. Chemistry – A European Journal. 2025. doi:10.1002/chem.202501624
BibTeX
@article{Yu2025,
author = {Yu, Qiqi and Chen, Sina and Yu, Liping and Xu, Dongdong and Yin, Shouchun},
title = {Cathepsin L‐Activatable Fluorescent Probe for Real‐Time Monitoring of Drug‐Resistant Breast Cancer Cells},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202501624}
}
EUVIMED